Author: Shailesh V. Shrikhande, Chief, GI and HPB Surgery, Tata Memorial Hospital, Mumbai.
Published: September 2015 — Volume 12, Issue 3 of Apollo Medicine.
DOI: 10.1016/j.apme.2015.07.017
Colorectal cancer in India presents a distinct epidemiological profile compared to Western nations, with rising incidence rates that demand urgent clinical attention. The condition often presents at younger ages and at more advanced stages, contributing to higher morbidity and mortality. Management challenges are compounded by limited awareness, delayed diagnosis, and variability in treatment access across different regions. Healthcare systems continue working to establish standardized screening protocols and treatment guidelines tailored to the Indian population. Research efforts focus on understanding the unique biological and environmental factors driving these patterns, while clinicians emphasize the importance of early detection and multidisciplinary care approaches to improve patient outcomes.
The role of biomarkers in colorectal cancer management has gained significant attention among Indian researchers and clinicians. Identifying reliable molecular markers can aid in early diagnosis, prognosis assessment, and treatment selection for individual patients. Studies continue to explore how genetic and epigenetic alterations influence disease progression and therapeutic response in the Indian context. This research aligns with broader global efforts to personalize cancer care, though implementation faces practical hurdles including cost constraints and infrastructure limitations. Collaborative studies between major cancer centers and regional hospitals are helping build a more comprehensive understanding of how biomarker-driven strategies can be integrated into routine clinical practice across diverse healthcare settings.
Surgical management remains the cornerstone of treatment for localized colorectal cancer, with advances in minimally invasive techniques improving recovery outcomes. However, access to specialized surgical care and adjuvant therapies varies considerably across India, creating disparities in treatment quality and survival rates. Public health initiatives aim to strengthen cancer care delivery systems, from early detection programs in community settings to referral networks connecting patients with tertiary care centers. Ongoing clinical studies evaluate the efficacy of various treatment protocols, including chemotherapy regimens and targeted therapies, specifically in Indian patient populations. These efforts collectively seek to reduce the burden of colorectal cancer and improve long-term survival prospects nationwide.
Colorectal cancer presents a growing clinical challenge in India, with unique epidemiological patterns and management hurdles distinct from those seen in Western populations. This article examines the scope of the problem, including late-stage presentation, limited screening uptake, and disparities in access to multidisciplinary care. The author discusses surgical approaches, perioperative strategies, and the role of adjuvant therapies tailored to resource-constrained settings.
